Trial Profile
Effect of alogliptin on endothelial dysfunction induced by postprandial hyperlipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2013
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 13 Aug 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 03 Jul 2012 New trial record